Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes

23Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: To study the influence of CYP2D6*10 on the formation of p-hydroxymexiletine (PHM) and hydroxymethylmexiletine (HMM) using microsomes from human liver of known genotypes. Methods: Microsomes from human livers of genotype CYP2D6*1/*1 (n = 5), *1/*10 (n = 6) and *10/*10 (n = 6) were used in this study. The formation of PHM and HMM was determined by high-performance liquid chromatography. Results: The formation rates of PHM and HMM were decreased by more than 50% and 85% in CYP2D6*1/*10 and *10/*10 microsomes, respectively, compared with *1/*1 microsomes. Conclusions: The metabolism of mexiletine to form PHM and HMM appears to be impaired to a significant extent in human liver microsomes from hetero- and homozygotes of CYP2D6*10.

Cite

CITATION STYLE

APA

Senda, C., Yamaura, Y., Kobayashi, K., Fujii, H., Minami, H., Sasaki, Y., … Chiba, K. (2001). Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes. British Journal of Clinical Pharmacology, 52(1), 100–103. https://doi.org/10.1046/j.0306-5251.2001.01411.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free